Patents Assigned to CollabRx Inc.
  • Method to treat melanoma in BRAF inhibitor-resistant subjects
    Patent number: 8426418
    Abstract: Methods to treat cancer patients, especially melanoma patients, who have BRAF mutations and have become resistant to BRAF mutant kinase inhibitors employ inhibitors of multiple receptor tyrosine kinases. In addition, methods are described for identifying pharmaceutical compositions and drugs that will be successful in treating these patients.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: April 23, 2013
    Assignee: CollabRx Inc.
    Inventors: Robert Coopersmith, Raphael Lehrer
  • METHOD TO TREAT MELANOMA IN BRAF INHIBITOR-RESISTANT SUBJECTS
    Publication number: 20120053185
    Abstract: Methods to treat cancer patients, especially melanoma patients, who have BRAF mutations and have become resistant to BRAF mutant kinase inhibitors employ inhibitors of multiple receptor tyrosine kinases. In addition, methods are described for identifying pharmaceutical compositions and drugs that will be successful in treating these patients.
    Type: Application
    Filed: August 26, 2011
    Publication date: March 1, 2012
    Applicant: CollabRx Inc.
    Inventors: Robert COOPERSMITH, Raphael Lehrer